Hester Biosciences Share Price rises 8.36% as Hester Biosciences Ltd. (HESTERBIO) gains today
- September 4, 2026
- Posted by: Harsh Piplani
- Category: News
Hester Biosciences Share Price is trading at Rs 2,376.15, up 8.36% today, with market capitalisation at Rs 1,856.33 Cr as of 04 September 2026 at 1:18:31 PM IST. The move puts Hester Biosciences Ltd. among the notable gainers in the Indian stock market today, even though the latest Univest data confirms the price event but does not establish a company-specific catalyst. For investors tracking Hester Biosciences Share Price Today, the focus is on the pace of the rise, the turnover reading, and whether the fundamentals justify renewed attention. Univest data shows that the stock has moved sharply above the previous close during ongoing market trade, which is enough to place Hester Biosciences Stock News on the radar without adding speculation. The next checks for readers are valuation, sector context and whether the current move is being supported by business quality rather than sentiment alone.
Hester Biosciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,376.15 |
| Previous Close | Rs 2,192.85 |
| Today's Move | Rs 183.3 (+8.36%) |
| Open | Rs 2,192.4 |
| High | Rs 2,390.15 |
| Low | Rs 2,192.4 |
| Turnover | Rs 0.13 crore |
| Market Capitalisation | Rs 1,856.33 crore |
| Market Cap Category | Small Cap |
Hester Biosciences Ltd. (HESTERBIO) rose to Rs 2,376.15 from the previous close of Rs 2,192.85, a move of Rs 183.3 or 8.36%. The stock opened at Rs 2,192.4, reached a high of Rs 2,390.15, recorded a low of Rs 2,192.4.
Hester Biosciences Share Price Today shows a clear same-day price rise. The stock opened at Rs 2,192.40, matched the day low at Rs 2,192.40, and touched a high of Rs 2,390.15, while last traded at Rs 2,376.15 versus the previous close of Rs 2,192.85. That leaves a gain of Rs 183.30, or 8.36%, with turnover at Rs 0.13 Cr. For readers searching Hester Biosciences Share Price Live or Hester Biosciences Share Price Update, the message from today’s price action is straightforward: the move is firm, the intraday range is broad, and the stock is trading close to the day’s high rather than near the opening level. The latest Univest figures confirm the stock is drawing attention as a top gainer today, but the data on hand does not establish a company-specific trigger.
Hester Biosciences Ltd. (HESTERBIO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,856.33 crore |
| P/E Ratio | 13.7x |
| P/B Ratio | 4.1x |
| ROE | 17.05% |
| ROCE | 16.21% |
| EPS | Rs 160.08 |
| Book Value Per Share | Rs 534.78 |
| Dividend Yield | 0.5% |
Hester Biosciences Ltd. (HESTERBIO) fundamental metrics show P/E 13.7x, P/B 4.1x, ROE 17.05%, ROCE 16.21%. These figures provide context only and are not a buy or sell signal.
Hester Biosciences Ltd. has a market capitalisation of Rs 1856.33 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 13.7x, P/B at 4.1x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.05% and ROCE of 16.21%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 160.08, book value per share of Rs 534.78, dividend yield of 0.5%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.61x, median ROE of 11.79%, median ROCE of 13.66%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 13.7x |
| Benchmark Median P/E | 32.61x |
| Benchmark Average P/E | 48.83x |
| Benchmark P/E Range | 3.32x to 645.91x |
| Company P/B Ratio | 4.1x |
| Benchmark Median P/B | 2.89x |
| Company ROE | 17.05% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 16.21% |
| Benchmark Median ROCE | 13.66% |
| Company Market Capitalisation | Rs 1,856.33 crore |
| Benchmark Median Market Cap | Rs 730.27 crore |
Hester Biosciences Ltd. (HESTERBIO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Hester Biosciences Ltd. (HESTERBIO) has a P/E ratio of 13.7x, which is below the benchmark median of 32.61x, a difference of -57.99%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Hester Biosciences Ltd. (HESTERBIO) has a ROE of 17.05%, which is above the benchmark median of 11.79%, a difference of +44.61%. Hester Biosciences Ltd. (HESTERBIO) has a ROCE of 16.21%, which is above the benchmark median of 13.66%, a difference of +18.67%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,63,791.45 | 37.77 | 5.28 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,45,080.59 | 83.91 | 13.89 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,90,351.29 | 85.89 | 20.87 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,14,832.64 | 25.09 | 4.2 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,162.52 | 33.29 | 3.19 | 11.83 | 16 |
Hester Biosciences Ltd. (HESTERBIO) has a P/E ratio of 13.7x compared with the displayed peer median of 37.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 17.05% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 16.21% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Hester Biosciences Ltd. (HESTERBIO) has a market capitalisation of Rs 1,856.33 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Hester Biosciences
- Hester Biosciences Share Price is up 8.36% today and is trading well above the previous close.
- The stock touched Rs 2,390.15 during the move, keeping Hester Biosciences Share Price Today in focus for market participants.
- Hester Biosciences Fundamental Analysis shows ROE of 17.05% and ROCE of 16.21%, both useful context for stock analysis.
- Valuation remains grounded at a P/E of 13.7, which supports Hester Biosciences Stock News searches around relative pricing.
- The company sits in Healthcare and Pharmaceuticals & Drugs, a sector often followed closely in Market News and Stocks in News.
About Hester Biosciences
Hester Biosciences Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is known for its animal healthcare and vaccine-related business, which positions it within a specialised part of the broader pharmaceutical chain. That business profile matters because demand drivers, regulatory requirements and product cycles can differ from those of large human-pharma companies. For readers following Hester Biosciences Latest News or Hester Biosciences Company News, the key point is that this is a focused business rather than a broad diversified pharma platform. Its market cap of Rs 1,856.33 Cr and valuation metrics suggest a mid-sized niche player whose share price can move sharply when investor interest returns. Univest tracks such companies because company overview, financial ratios and market update context often matter more in smaller names than a single headline. Hester Biosciences Share Price therefore needs to be read in the context of business mix, sector placement and financial quality, not just one day’s move.
Frequently Asked Questions
Why is Hester Biosciences Share Price rising today?
Ans. Hester Biosciences Share Price is higher by 8.36% today, but the latest Univest data confirms the price event without establishing a company-specific catalyst. The move reflects active market interest during ongoing trade.
What is Hester Biosciences Share Price Today?
Ans. Hester Biosciences Share Price Today is Rs 2,376.15. It is trading above the previous close of Rs 2,192.85 and has moved within a range between Rs 2,192.40 and Rs 2,390.15.
How much has Hester Biosciences Share Price gained today?
Ans. Hester Biosciences Share Price has gained Rs 183.30 today, which works out to 8.36%. That places the stock among the notable gainers in market trade as of 04 September 2026 at 1:18:31 PM IST.
What is Hester Biosciences market capitalisation?
Ans. Hester Biosciences has a market capitalisation of Rs 1,856.33 Cr. This size places it well below large healthcare peers and helps explain why the stock can react sharply to buying interest.
Is Hester Biosciences expensive based on valuation?
Ans. Hester Biosciences trades at a P/E of 13.7 and a P/B of 4.1. Against the industry benchmark, the P/E is below the median and average, while the P/B is close to the benchmark average.
How do Hester Biosciences fundamentals look?
Ans. Hester Biosciences shows ROE of 17.05% and ROCE of 16.21%, both above the same-industry median. EPS is Rs 160.08, book value is Rs 534.78 and dividend yield is 0.5%.
How does Hester Biosciences compare with healthcare peers?
Ans. Hester Biosciences Share Price sits in a much smaller company than Sun Pharma, Divi’s, Torrent, Zydus and Cipla. Its valuation is lower than several peers, while return ratios remain competitive.
Where can investors track Hester Biosciences Share Price Live?
Ans. Investors can track Hester Biosciences Share Price Live on Univest for price updates, financial ratios, market cap, 52-week levels and sector context. That keeps the stock’s move in a broader research frame.
Track Hester Biosciences Share Price on Univest
Use Hester Biosciences Ltd. (HESTERBIO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Hester Biosciences Share Price on Univest to follow live share price movement, company ratios, market cap, 52-week levels, financial analysis and sector comparison in one place. Univest also helps readers review Hester Biosciences Share Price Today alongside broader Hester Biosciences Stock Analysis and Hester Biosciences Stock News. That makes it easier to compare price action with fundamentals and industry context without relying on scattered market updates.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
